InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,598.80
(
1.03%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.36
(
-0.14%
)
Bitcoin
63,397.68
(
0.37%
)
Post# of 2676
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

a surfer

Send PM Follow Ignore
Followers 80
Posts 6945
Boards Moderated 0
Alias Born 07/30/2006

a surfer

Re: WolfOfGrnStreet post# 1042

Monday, 01/29/2018 3:13:13 PM

Monday, January 29, 2018 3:13:13 PM

Post# of 2676
ANALYST ACTIONS: LADENBURG THALMANN INITIATES ZYNERBA PHARMACEUTICALS WITH A BUY; PT SET AT $25.50
1 hour 29 minutes ago - CFRA
01:42 PM EST, 01/29/2018 (MT Newswires) -- Ladenburg Thalmann initiates coverage of Zynerba Pharmaceuticals (ZYNE) with a buy. MTNewswire
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ZYNE News
More ZYNE News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!